MMP9 and neoplasm: Further research on the underlying mechanism by transcriptome sequencing revealed that ADEs act mainly on the Wnt signaling pathway, inhibiting the expression of the Wnt5a, β-catenin, MMP-9 and MMP-2 proteins in the signaling pathway in a dose-dependent manner, thus reducing the invasion, metastasis and angiogenesis of tumor cells.